mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |